Mounjaro is an innovative weight management medication that supports blood sugar control and encourages substantial weight loss. Delivered via subcutaneous injection, it mimics natural hormones that influence appetite and insulin regulation. As part of a personalised treatment plan—including diet and exercise—Mounjaro is tailored by healthcare professionals to meet each patient’s unique needs. For individuals facing challenges with weight management, it offers a promising solution under the expert care of specialists at Heba Weight Loss Clinic.


Mounjaro’s active ingredient is tirzepatide. The inactive ingredients may differ and can be reviewed during a consultation. Be sure to inform your healthcare provider about any allergies or sensitivities to help prevent potential adverse reactions.
In clinical trials, participants with obesity or excess weight who used Mounjaro alongside a reduced-calorie diet and increased physical activity lost an average of 15% to over 20% of their body weight over 72 weeks, depending on the dose. While individual results may differ, many patients begin to see noticeable weight loss within the first few months.


As with any medication, Mounjaro can cause side effects. Common side effects include nausea, diarrhoea, vomiting, constipation, and abdominal pain. More serious side effects can also occur; we advise patients to contact their healthcare provider immediately if they experience any severe or concerning symptoms.